ArticleEndocrine pathology2011
Sellar glomangioma.
Article in Endocrine pathology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 12 citations in OpenAlex.
- Primary sellar glomus tumor with BRAF K601E mutation: an aggressive tumor of uncertain malignant potential.Brain tumor pathology · 2026Review
- Primary glomangioma of the chest wall: case report and review of literature.Journal of surgical case reports · 2025Article
- Sellar Glomus Tumor Misdiagnosed as Pituitary Adenoma: A Case Report and Review of the Literature.Frontiers in endocrinology · 2022Review
- Primary glomus tumour of the pituitary gland: diagnostic challenges of a rare and potentially aggressive neoplasm.Virchows Archiv : an international journal of pathology · 2021Article
- Hypothalamic Endocrine Tumors: An Update.Journal of clinical medicine · 2019Review
- TFE3-Expressing Perivascular Epithelioid Cell Neoplasm (PEComa) of the Sella Turcica.Endocrine pathology · 2017Article
- Gastric glomus tumor: clinical conundrums and potential mimic of gastrointestinal stromal tumor (GIST).International journal of clinical and experimental pathology · 2017Article
- Malignant glomus tumor of the thyroid gland where is heretofore an unreported organ: a case report and literature review.Endocrine pathology · 2015Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Glomus tumors of the sellar region are exceedingly rare with only two reported cases in the literature. A case of a sellar glomangioma in a 72-year-old man is described. The tumor had the radiographic and gross appearance of a pituitary adenoma. Microscopically, the tumor was composed of epithelioid cells surrounding prominent small vascular channels. The tumor cells had indistinct cell borders and monotonous nuclei. Histological and immunohistochemical analysis identified the sellar tumor as a glomangioma. Here, we report the clinicopathological features of a third case of a sellar glomus tumor and review the literature.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.